Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04231877
Brief Title: Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma

First Submitted : January 14, 2020
First Submitted that Met QC Criteria : January 14, 2020
First Posted : January 18, 2020

Last Update Submitted that Met QC Criteria : June 9, 2021
Last Update Posted : June 14, 2021